Results 81 to 90 of about 2,055 (186)

Mitigating off‐target effects of small RNAs: conventional approaches, network theory and artificial intelligence

open access: yesBritish Journal of Pharmacology, Volume 182, Issue 2, Page 340-379, January 2025.
Abstract Three types of highly promising small RNA therapeutics, namely, small interfering RNAs (siRNAs), microRNAs (miRNAs) and the RNA subtype of antisense oligonucleotides (ASOs), offer advantages over small‐molecule drugs. These small RNAs can target any gene product, opening up new avenues of effective and safe therapeutic approaches for a wide ...
Zoltán Bereczki   +14 more
wiley   +1 more source

Neuro‐Ophthalmic Manifestation Associated With COVID‐19 in a Tertiary Eye Center in Nepal

open access: yesCase Reports in Ophthalmological Medicine, Volume 2025, Issue 1, 2025.
The coronavirus disease 2019 (COVID‐19) primarily involves the respiratory system, but can manifest with a variety of neuro‐ophthalmic symptoms. Here, we describe three cases presenting with neuro‐ophthalmic manifestations secondary to COVID‐19 at a tertiary center in Nepal.
Sanjeeta Sitaula   +4 more
wiley   +1 more source

Non‐arteritic anterior ischemic optic neuropathy due to hypovolemia

open access: yesActa Ophthalmologica, 2019
AbstractPurposeTo present a case of non‐arteritic anterior ischemic optic neuropathy due to hypovolemia.MethodsA 54 year‐old male was referred to the ophthalmology department with a history of blurred vision in his right eye following acute bleeding due to duodenal ulcer 5 days ago.
Georgios Bontzos   +4 more
openaire   +1 more source

Protecting Sight During Cardiac Surgery: Mechanisms, Risks, and Management of Perioperative Ocular Complications

open access: yesJournal of Cardiac Surgery, Volume 2025, Issue 1, 2025.
Ophthalmic complications during a major cardiac surgery are rare but may have serious consequences. Patients requiring intraoperative support from a cardiopulmonary bypass machine have an increased risk of developing ocular adverse effects because of significant hemodynamic alterations involving the systemic and ocular vasculature.
Ye In Christopher Kwon   +13 more
wiley   +1 more source

[Non-arteritic anterior ischemic optic neuropathy--case reports].

open access: yesKlinika oczna, 2004
Nonarteritic anterior ischaemic optic neuropathy usually caused by hypertension, diabetes and hypercholesterolaemia is quite a common disease. Within its symptoms two are the most important: deep and often not reversible visual aquity loss and visual field defects.
Krystyna, Kazimierczuk   +2 more
openaire   +1 more source

Non-arteritic anterior ischemic optic neuropathy with Cilioretinal artery occlusion: a case report

open access: yesBMC Ophthalmology, 2019
Background To describe a peculiar case of concurrent non-arteritic anterior ischemic optic neuropathy (NAION) and cilioretinal arteries occlusion (CLRAO) without other causative agents which responded well to intravenous and intravitreal injection of ...
Ya-Yun Yang, Ming-Shan He
doaj   +1 more source

Glucagon‐like peptide 1 (GLP1) receptor agonists and risk for ischemic optic neuropathy: A meta‐analysis of randomised controlled trials

open access: yes
Diabetes, Obesity and Metabolism, Volume 27, Issue 2, Page 1005-1009, February 2025.
Giovanni Antonio Silverii   +3 more
wiley   +1 more source

Anterior ischemic optic neuropathy precipitated by acute primary angle closure

open access: yesIndian Journal of Ophthalmology, 2010
A 59-year-old man with a history of longstanding systemic hypotension developed asymmetric non-arteritic anterior ischemic optic neuropathy (NAION) apparently precipitated by bilateral sequential acute primary angle closure. NAION is very rarely reported
Choudhari Nikhil   +3 more
doaj  

A Case of Non-Arteritic Anterior Ischemic Optic Neuropathy with COVID-19 [PDF]

open access: diamond, 2020
Jonathan Rho   +4 more
openalex   +1 more source

Home - About - Disclaimer - Privacy